Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>Daclatasvir Impurity F

Daclatasvir Impurity F

Daclatasvir Impurity F Structure
Daclatasvir Impurity F structure
CAS No.
1007884-60-7
Chemical Name:
Daclatasvir Impurity F
Synonyms
Daclatasvir Impurity 40;Monodes(N-carboxymethyl)valine Daclatasvir;methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-{5-[4-(4-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}phenyl)phenyl]-1H-imidazol-2-yl}pyrrolidin-1-yl]butan-2-yl]carbamate;Methyl ((S)-3-methyl-1-oxo-1-((S)-2-(5-(4''-(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1''-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)butan-2-yl)carbamate;Carbamic acid, N-[(1S)-2-methyl-1-[[(2S)-2-[5-[4'-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]-, methyl ester;Daclatasvir impurity 14/Monodes(N-carboxymethyl)valine Daclatasvir/N-[(1S)-2-Methyl-1-[[(2S)-2-[5-[4’-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1’-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]carbamic Acid Methyl Ester
CBNumber:
CB03154294
Molecular Formula:
C33H39N7O3
Molecular Weight:
581.71
MDL Number:
MOL File:
1007884-60-7.mol
Last updated:2023-07-20 08:28:02
Request For Quotation

Daclatasvir Impurity F Properties

Boiling point 963.0±65.0 °C(Predicted)
Density 1.239±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
pka 11.22±0.46(Predicted)

Daclatasvir Impurity F price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
TRC M537990 Monodes(N-carboxymethyl)valineDaclatasvir 1007884-60-7 1mg $75 2021-12-16 Buy
ChemScene CS-0116105 Monodes(N-carboxymethyl)valineDaclatasvir 1007884-60-7 5mg $400 2021-12-16 Buy
ChemScene CS-0116105 Monodes(N-carboxymethyl)valineDaclatasvir 1007884-60-7 10mg $680 2021-12-16 Buy
Product number Packaging Price Buy
M537990 1mg $75 Buy
CS-0116105 5mg $400 Buy
CS-0116105 10mg $680 Buy

Daclatasvir Impurity F Chemical Properties,Uses,Production

Uses

Monodes(N-carboxymethyl)valine Daclatasvir is an impurity of Daclatasvir (D101500); a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV).

Daclatasvir Impurity F synthesis

1007884-59-4
1007884-60-7
Synthesis of Daclatasvir Impurity F from 1-Pyrrolidinecarboxylic acid, 2-[5-[4'-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-, 1,1-dimethylethyl ester, (2S)-

Daclatasvir Impurity F Preparation Products And Raw materials

Raw materials

Preparation Products

Daclatasvir Impurity F Suppliers

Global( 32)Suppliers
Supplier Tel Email Country ProdList Advantage
Standardpharm Co. Ltd. 		86-714-3992388 overseasales1@yongstandards.com United States 14336 58
BOC Sciences 		+1-631-485-4226 inquiry@bocsci.com United States 19553 58
sgtlifesciences pvt ltd 		+8617013299288 dj@sgtlifesciences.com China 12382 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522 overseasales@yongstandards.com China 11927 58
Shanghai Famo Bio-chemical Technology Company Ltd. +862136680027 15800370750 sales@famobiotech.com China 500 56
ChemStrong Scientific Co.,Ltd 0755-66853366 13670046396 sales@chem-strong.com China 17982 56
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 18892239720 psaitong@jm-bio.com China 12308 58
Lynnchem 86-(0)29-85992781 17792393971 info@lynnchem.com China 4587 58
Novachemistry 44-20819178-90 02081917890 info@novachemistry.com United Kingdom 4381 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 17825480238 3008233717@qq.com China 9844 12
Supplier Advantage
Standardpharm Co. Ltd. 		58
BOC Sciences 		58
sgtlifesciences pvt ltd 		58
China National Standard Pharmaceutical Corporation Limited 		58
Shanghai Famo Bio-chemical Technology Company Ltd. 56
ChemStrong Scientific Co.,Ltd 56
Beijing Jin Ming Biotechnology Co., Ltd. 58
Lynnchem 58
Novachemistry 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 12

1007884-60-7(Daclatasvir Impurity F)Related Search:

Daclatasvir Impurity Daclatasvir Impurity 1 1,1'-[1,1'-biphenyl]-4,4'-diylbis[2,2-dibromo]-ethanone Daclatasvir Impurity 7 Daclatasvir Dihydrochloride
methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate 1-{4'-acetyl-[1,1'-biphenyl]-4-yl}-2-bromoethan-1-one Daclatasvir Impurity 5 (SRSS-Isomer)

1of2

Monodes(N-carboxymethyl)valine Daclatasvir Daclatasvir impurity 14/Monodes(N-carboxymethyl)valine Daclatasvir/N-[(1S)-2-Methyl-1-[[(2S)-2-[5-[4’-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1’-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]carbamic Acid Methyl Ester methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-{5-[4-(4-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}phenyl)phenyl]-1H-imidazol-2-yl}pyrrolidin-1-yl]butan-2-yl]carbamate Daclatasvir Impurity 40 Methyl ((S)-3-methyl-1-oxo-1-((S)-2-(5-(4''-(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1''-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)butan-2-yl)carbamate Carbamic acid, N-[(1S)-2-methyl-1-[[(2S)-2-[5-[4'-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]-, methyl ester 1007884-60-7 C33H39N7O3